NO20030870L - Bicyclic heterocycles, drugs containing them, their use and the method of preparation thereof - Google Patents

Bicyclic heterocycles, drugs containing them, their use and the method of preparation thereof

Info

Publication number: NO20030870L
Authority: NO; Norway
Prior art keywords: preparation; drugs containing; bicyclic heterocycles; heterocycles; bicyclic
Prior art date: 2000-08-26

Application number

NO20030870A

Other languages

Norwegian (no)

Other versions

NO324866B1 (en

NO20030870D0 (en

Inventor

Frank Himmelsbach

Elke Langkopf

Birgit Jung

Stefan Blech

Flavio Solca

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-26

Filing date

2003-02-25

Publication date

2003-02-25

2003-02-25 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-02-25 Publication of NO20030870L publication Critical patent/NO20030870L/en

2003-02-25 Publication of NO20030870D0 publication Critical patent/NO20030870D0/en

2007-12-17 Publication of NO324866B1 publication Critical patent/NO324866B1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Immunology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20030870A 2000-08-26 2003-02-25 Bicyclic heterocycles, drugs containing them, their use in the manufacture of drugs for the treatment of diseases, and methods for the preparation thereof NO324866B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10042058A DE10042058A1 (en)	2000-08-26	2000-08-26	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
PCT/EP2001/009532 WO2002018351A1 (en)	2000-08-26	2001-08-18	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof

Publications (3)

Publication Number	Publication Date
NO20030870L true NO20030870L (en)	2003-02-25
NO20030870D0 NO20030870D0 (en)	2003-02-25
NO324866B1 NO324866B1 (en)	2007-12-17

Family

ID=7653945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030870A NO324866B1 (en)	2000-08-26	2003-02-25	Bicyclic heterocycles, drugs containing them, their use in the manufacture of drugs for the treatment of diseases, and methods for the preparation thereof

Country Status (30)

Country	Link
EP (1)	EP1315705A1 (en)
JP (1)	JP4834282B2 (en)
KR (1)	KR100862873B1 (en)
CN (1)	CN100404517C (en)
AR (1)	AR033562A1 (en)
AU (2)	AU2001287694B2 (en)
BG (1)	BG107559A (en)
BR (1)	BR0113519A (en)
CA (1)	CA2417897C (en)
CZ (1)	CZ302567B6 (en)
DE (1)	DE10042058A1 (en)
EA (1)	EA005679B1 (en)
EC (1)	ECSP034464A (en)
EE (1)	EE05269B1 (en)
HR (1)	HRP20030138A2 (en)
HU (1)	HUP0300819A3 (en)
IL (2)	IL154602A0 (en)
ME (1)	MEP58708A (en)
MX (1)	MXPA03001483A (en)
MY (1)	MY126132A (en)
NO (1)	NO324866B1 (en)
NZ (1)	NZ524668A (en)
PL (1)	PL360248A1 (en)
RS (1)	RS52279B (en)
SK (1)	SK287747B6 (en)
TW (1)	TWI294422B (en)
UA (1)	UA73004C2 (en)
UY (1)	UY26903A1 (en)
WO (1)	WO2002018351A1 (en)
ZA (1)	ZA200300991B (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA01012899A (en)	1999-06-21	2002-07-30	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof.
DE10042059A1 (en) *	2000-08-26	2002-03-07	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
US7019012B2 (en)	2000-12-20	2006-03-28	Boehringer Ingelheim International Pharma Gmbh & Co. Kg	Quinazoline derivatives and pharmaceutical compositions containing them
TW200813014A (en) *	2002-03-28	2008-03-16	Astrazeneca Ab	Quinazoline derivatives
DE10214412A1 (en) *	2002-03-30	2003-10-09	Boehringer Ingelheim Pharma	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and process for their preparation
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
MXPA04009536A (en) *	2002-03-30	2005-01-25	Boehringer Ingelheim Pharma	4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors.
US7576074B2 (en)	2002-07-15	2009-08-18	Rice Kenneth D	Receptor-type kinase modulators and methods of use
DE10326186A1 (en)	2003-06-06	2004-12-23	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10334226A1 (en) *	2003-07-28	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
ES2305844T3 (en)	2003-09-16	2008-11-01	Astrazeneca Ab	DERIVATIVES OF QUINAZOLINE AS INHIBITORS OF THYROSINE KINASE.
DE602004004553T2 (en)	2003-09-19	2007-10-25	Astrazeneca Ab	quinazoline derivatives
PL2392565T3 (en)	2003-09-26	2014-08-29	Exelixis Inc	c-Met modulators and methods of use
US7456189B2 (en)	2003-09-30	2008-11-25	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10345875A1 (en) *	2003-09-30	2005-04-21	Boehringer Ingelheim Pharma	Bicyclic heterocycles, pharmaceutical compositions containing them, their use and methods of preparation
DE10350717A1 (en) *	2003-10-30	2005-06-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (en)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
JP5054544B2 (en)	2005-02-26	2012-10-24	アストラゼネカアクチボラグ	Quinazoline derivatives as tyrosine kinase inhibitors
KR100673775B1 (en) *	2005-04-08	2007-01-24	엘지전자 주식회사	Refrigerator Home Bar
CA2619037A1 (en) *	2005-08-22	2007-03-01	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
CA2833706C (en)	2005-11-11	2014-10-21	Boehringer Ingelheim International Gmbh	Quinazoline derivatives for the treatment of cancer diseases
CA2643363A1 (en) *	2006-03-09	2007-09-13	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
RU2492864C2 (en)	2006-09-18	2013-09-20	Бёрингер Ингельхайм Интернациональ Гмбх	Method of treating cancer carrying egfr mutations
EP1921070A1 (en)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
US7998949B2 (en)	2007-02-06	2011-08-16	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
BRPI0907916A2 (en)	2008-02-07	2015-07-28	Boehringer Ingelheim Int	Spirocycle heterocycles, medicaments containing such compounds, and processes for preparing them
WO2009138781A1 (en)	2008-05-13	2009-11-19	Astrazeneca Ab	Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
US8648191B2 (en)	2008-08-08	2014-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
TW201920110A (en)	2009-01-16	2019-06-01	美商艾克塞里克斯公司	Containing N-(4-{[6,7-bis(methoxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-di Pharmaceutical composition of methotrexate malate and use thereof
LT2451445T (en)	2009-07-06	2019-06-25	Boehringer Ingelheim International Gmbh	Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
UA108618C2 (en)	2009-08-07	2015-05-25		APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT
KR101317809B1 (en)	2011-06-07	2013-10-16	한미약품 주식회사	Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cell and non-metalic salt lubricant
KR20140096571A (en)	2013-01-28	2014-08-06	한미약품 주식회사	Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
BR112015020787B1 (en)	2013-03-06	2022-12-06	Astrazeneca Ab	4-(SUBSTITUTED-ANILINE)-6-O-(SUBSTITUTED-PIPERIZINE-CARBONYL)QUINAZOLINIC COMPOUNDS, THEIR SALTS, PHARMACEUTICAL COMPOSITION, USE AND COMBINATION
US9242965B2 (en)	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
DK3126354T3 (en) *	2014-04-04	2020-03-09	H Lundbeck As	HALOGENATED QUINAZOLINE-THF AMINES AS PDE1 INHIBITORS
US20170176028A1 (en)	2015-12-18	2017-06-22	Lg Electronics Inc.	Air conditioner
CN110291104B (en)	2016-11-17	2023-11-03	得克萨斯州大学系统董事会	Compounds with antitumor activity against cancer cells harboring EGFR or HER2 exon 20 mutations
CN112321814B (en) *	2020-12-30	2021-03-23	广州初曲科技有限公司	Preparation and application of gefitinib idebenone conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9508538D0 (en) *	1995-04-27	1995-06-14	Zeneca Ltd	Quinazoline derivatives
GB9624482D0 (en) *	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
BR9707495A (en) *	1996-02-13	1999-07-27	Zeneca Ltd	Quinazoline derivative process for the preparation of the same pharmaceutical composition and process for the production of an antiangiogenic effect and / or reduction of vascular permeability in a warm-blooded animal
GB9603095D0 (en) *	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline derivatives
AU719327B2 (en) *	1996-03-05	2000-05-04	Astrazeneca Ab	4-anilinoquinazoline derivatives
NZ332119A (en) *	1996-04-12	2001-08-31	Warner Lambert Co	Quinazoline compounds which are irreversible inhibitors of tyrosine kinases
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
DE19911509A1 (en) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation

2000
- 2000-08-26 DE DE10042058A patent/DE10042058A1/en not_active Ceased
2001
- 2001-08-18 AU AU2001287694A patent/AU2001287694B2/en not_active Ceased
- 2001-08-18 EA EA200300219A patent/EA005679B1/en not_active IP Right Cessation
- 2001-08-18 NZ NZ524668A patent/NZ524668A/en not_active IP Right Cessation
- 2001-08-18 CA CA002417897A patent/CA2417897C/en not_active Expired - Fee Related
- 2001-08-18 AU AU8769401A patent/AU8769401A/en active Pending
- 2001-08-18 EE EEP200300077A patent/EE05269B1/en not_active IP Right Cessation
- 2001-08-18 SK SK231-2003A patent/SK287747B6/en not_active IP Right Cessation
- 2001-08-18 PL PL36024801A patent/PL360248A1/en not_active Application Discontinuation
- 2001-08-18 IL IL15460201A patent/IL154602A0/en unknown
- 2001-08-18 HU HU0300819A patent/HUP0300819A3/en unknown
- 2001-08-18 JP JP2002523469A patent/JP4834282B2/en not_active Expired - Fee Related
- 2001-08-18 WO PCT/EP2001/009532 patent/WO2002018351A1/en not_active Ceased
- 2001-08-18 BR BR0113519-8A patent/BR0113519A/en not_active Application Discontinuation
- 2001-08-18 EP EP01967285A patent/EP1315705A1/en not_active Ceased
- 2001-08-18 KR KR1020037002744A patent/KR100862873B1/en not_active Expired - Fee Related
- 2001-08-18 CN CNB01814635XA patent/CN100404517C/en not_active Expired - Fee Related
- 2001-08-18 CZ CZ20030870A patent/CZ302567B6/en not_active IP Right Cessation
- 2001-08-18 RS YU14003A patent/RS52279B/en unknown
- 2001-08-18 MX MXPA03001483A patent/MXPA03001483A/en active IP Right Grant
- 2001-08-18 ME MEP-587/08A patent/MEP58708A/en unknown
- 2001-08-18 UA UA2003032533A patent/UA73004C2/en unknown
- 2001-08-18 HR HR20030138A patent/HRP20030138A2/en not_active Application Discontinuation
- 2001-08-23 UY UY26903A patent/UY26903A1/en not_active Application Discontinuation
- 2001-08-24 AR ARP010104041A patent/AR033562A1/en unknown
- 2001-08-24 MY MYPI20013985A patent/MY126132A/en unknown
- 2001-08-24 TW TW090120905A patent/TWI294422B/en not_active IP Right Cessation
2003
- 2003-02-03 EC EC2003004464A patent/ECSP034464A/en unknown
- 2003-02-05 ZA ZA200300991A patent/ZA200300991B/en unknown
- 2003-02-14 BG BG107559A patent/BG107559A/en unknown
- 2003-02-24 IL IL154602A patent/IL154602A/en not_active IP Right Cessation
- 2003-02-25 NO NO20030870A patent/NO324866B1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2417897C (en)	2009-03-31
MY126132A (en)	2006-09-29
CN1449390A (en)	2003-10-15
PL360248A1 (en)	2004-09-06
SK287747B6 (en)	2011-08-04
NO324866B1 (en)	2007-12-17
HUP0300819A2 (en)	2003-09-29
AU8769401A (en)	2002-03-13
CA2417897A1 (en)	2003-01-30
AU2001287694B2 (en)	2007-09-06
HUP0300819A3 (en)	2008-03-28
CN100404517C (en)	2008-07-23
EE05269B1 (en)	2010-02-15
YU14003A (en)	2006-01-16
MXPA03001483A (en)	2003-06-06
UA73004C2 (en)	2005-05-16
EP1315705A1 (en)	2003-06-04
ZA200300991B (en)	2004-04-16
BR0113519A (en)	2003-07-01
IL154602A (en)	2008-07-08
UY26903A1 (en)	2002-03-22
NZ524668A (en)	2006-06-30
HRP20030138A2 (en)	2005-04-30
KR100862873B1 (en)	2008-10-15
IL154602A0 (en)	2003-09-17
MEP58708A (en)	2011-05-10
HK1057557A1 (en)	2004-04-08
ECSP034464A (en)	2003-03-31
JP2004507529A (en)	2004-03-11
JP4834282B2 (en)	2011-12-14
CZ302567B6 (en)	2011-07-13
EA005679B1 (en)	2005-04-28
SK2312003A3 (en)	2003-10-07
EE200300077A (en)	2004-12-15
AR033562A1 (en)	2003-12-26
WO2002018351A1 (en)	2002-03-07
EA200300219A1 (en)	2003-08-28
NO20030870D0 (en)	2003-02-25
KR20030024914A (en)	2003-03-26
TWI294422B (en)	2008-03-11
DE10042058A1 (en)	2002-03-07
BG107559A (en)	2003-10-31
RS52279B (en)	2012-10-31

Publication	Publication Date	Title
NO20030870D0 (en)	2003-02-25	Bicyclic heterocycles, drugs containing them, their use and the method of preparation thereof
NO20016185D0 (en)	2001-12-18	Bicyclic heterocycles, drugs containing these compounds, their use and method of preparation of
NO20032726D0 (en)	2003-06-16	Quinazoline derivatives, medicaments containing these compounds, their use and method of preparation thereof
DK0966454T3 (en)	2003-09-01	Disubstituted bicyclic heterocycles, their preparation and their use as drugs
DE60100313D1 (en)	2003-07-03	Release system of cyclopropene derivatives
NO20032735L (en)	2003-08-06	Diphenyllazetidinone derivatives, process for their preparation, drugs containing these compounds and their use
NO20040469L (en)	2004-04-30	Heterocyclic compounds and their preparation and use
NO20032733L (en)	2003-08-14	Diphenyllazetidinone derivatives, process for their preparation, drugs containing these compounds and their use
DK1112251T3 (en)	2003-09-01	Acetidine derivatives, their preparation and drugs containing these derivatives
DE60115418D1 (en)	2006-01-05	MICROINFUSION DEVICE FOR THE ADMINISTRATION OF MEDICAMENTS
CY2007029I2 (en)	2009-11-04	METHOD FOR THE PREPARATION OF SUBSTITUTED OCTANOYL-AMIDES
EE05387B1 (en)	2011-02-15	Quinazoline Derivatives, Method of Preparation and Use
FI7846U1 (en)	2008-04-28	Pharmaceutical preparation containing oxycodone and naloxone
AU2001287694A1 (en)	2002-06-06	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
NO20032187D0 (en)	2003-05-14	Heterocyclylalkylpiperidine derivatives, their preparation and preparations containing the compounds
DK1128831T3 (en)	2005-01-17	Pharmaceutical moxifloxacin preparation
DK1098874T3 (en)	2003-10-06	Benzocycloheptenes, Methods of Preparation, Pharmaceutical Preparations Containing Them, and Their Use in the Preparation of Drugs
NO20022021D0 (en)	2002-04-29	Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, the preparation of the same and their use as anorexic drugs
NO20016404L (en)	2002-03-01	Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
NO20024105L (en)	2002-10-28	Memnopeptides, Methods for their Preparation and Use
DK1176148T3 (en)	2004-01-05	Benzothiadiazine Compounds, Methods of Preparation and Pharmaceutical Compositions Containing These
DK1341758T3 (en)	2006-10-30	Coniosetin and its derivatives, process for the preparation and use of the same
NO20054130D0 (en)	2005-09-06	Quaternary chelidonin and alkaloid derivatives, processes for the preparation of the same, and their use for the preparation of medicaments
HU0200306D0 (en)	2002-04-29	Method for preparation of absorbent article, the absorbent article and application of it
DE60214533D1 (en)	2006-10-19	PYRIDOINDOLON DERIVATIVES AND ANTIBODIES CONTAINING PHARMACEUTICAL MIXTURES

Legal Events

Date	Code	Title	Description
2013-03-25	MM1K	Lapsed by not paying the annual fees